Stephanie Kramer2021-05-20T11:55:20+00:0019-05-2021|News|
There is consensus among stakeholders that patient engagement at different points of the medicines lifecycle is critical to fostering patient access to innovative therapeutic solutions, and delivering better health outcomes for patients. IMI PARADIGM, a public private consortium consisting of patients, academia, industry, HTA bodies and regulators, developed a toolkit to make patient engagement [...]
Dominika Suchonova2021-05-18T07:35:14+00:0017-05-2021|News|
The European Brain Council is pleased to invite you to join us for the upcoming Value of Treatment for Brain Disorders Research Project “Case studies on Rare Diseases and Mental Disorders” Virtual Synthesis Meeting to be held on 8 June 2021 at 13:00-17:30. The Value of Treatment (VOT) is a health economics and outcomes research project addressing all brain disorders, conceptualized in 2015 by the [...]
admin_ebc2021-04-13T13:39:05+00:0031-03-2021|News|
The 3rd Brain Innovation Days digital event on "Fast-tracking brain innovation in times of COVID-19" will take place on 27 March 2021 (12:30 - 14:00 CET) The last 14 months have been a most testing time for the world in general and for global health in particular. COVID-19 took the world by surprise as [...]
Dominika Suchonova2021-10-26T10:05:46+00:0018-03-2021|
The European Brain Council (EBC) is pleased to invite you for the Value of Treatment 2 (VOT 2) Synthesis Meeting, to be held virtually on 8 June 2021 (13:00-17:00 CET). Experts participating in the research will present a synthesis of the results so far and examine the most critical issues in brain diseases in Europe from different perspectives including policymakers, innovators, academia [...]
Dominika Suchonova2021-03-19T11:29:10+00:0018-03-2021|News|
The European Brain Council (EBC) is pleased to launch the Save the Date for the Value of Treatment 2 (VOT 2) Synthesis Meeting, to be held virtually on 8 June 2021 (13:00-17:00 CET). Experts participating in the research will present a synthesis of the results so far and examine the most critical issues in brain diseases in Europe [...]
